Klinisch-Molekularbiologisches Forschungszentrum

Targeting the roots of cancer metastasis and therapy resistance (BR 1399/17-1) July 1, 2023 - June 30, 2028 Zeb1-vermittelte Mechanismen der EMT-assoziierten Ferroptose-Empfindlichkeit Zeb1-vermittelte Mechanismen der EMT-assoziierten Ferroptose-Empfindlichkeit April 1, 2025 - March 31, 2028 Kinase signaling in the immune responses of small-cell lung cancer April 1, 2024 - April 1, 2027 Cancer cell colonization of the lung epithelium Sept. 1, 2023 - Sept. 1, 2026 Immune escape mechanisms in lung cancer April 1, 2023 - April 1, 2026 Mechanisms of metastasis in lung cancer April 1, 2023 - April 1, 2026 IZKF-N11 ERBB2 SCLC immune response(962): Deciphering ERBB2 dependent immune regulation in small cell lung cancer (SCLC) April 1, 2024 - March 31, 2026 D039: EMT specific splicing mediates ferroptosis sensitivity July 1, 2023 - Dec. 31, 2025 Metabolische Dysregulationen bei EMT-getriebener metastatischer Kolonisierung (A03) (SFB/TRR 305 A03) TRR 305: Über die Analyse der metastatischen Koloniebildung zu neuen systemischen Krebstherapien Jan. 1, 2021 - Dec. 31, 2024 Deciphering LIN28B as a biomarker in squamous cell lung carcinomas for treatment with PD-1/PD-L1 signaling blockade and evaluating combined anti-VEGFR2 with PD-1/PD-L1 signaling lockade as a novel therapy option Dec. 1, 2021 - Nov. 30, 2024